Yi-Bin Chen, MD is the Director of the Hematopoietic Cell Transplant and Cell Therapy Program at Massachusetts General Hospital. Yi-Bin is the inaugural Allan Rogers, Jr. and Cara J. Rogers Endowed Chair and an Associate Professor at Harvard Medical School. He has spent his career in clinical investigation with the goal of improving outcomes for […]
Team Role: Clinical
Eric Sievers, MD
Eric Sievers, MD, is currently Chief Medical Officer at BioAtla, Inc. Eric has over 25 years of clinical and translational biomedical research experience in multiple settings, including biotechnology industry, hospital- and clinic-based clinical practice and academics. During his nine years at Seattle Genetics, he was closely involved with the development and regulatory approval of ADCETRIS […]
Rob Soiffer
Rob Soiffer, MD is currently Chief of the Division of Hematologic Malignancies and Co-Director of the Adult Stem Cell Transplantation Program at the Dana-Farber Cancer Institute. He joined Dana-Farber in 1988 after completing a medical oncology fellowship also at Dana-Farber. Rob is Chairman of the Center for International Blood and Marrow Transplant Research advisory committee […]
Hans-Peter Kiem, MD, PhD
The research of Hans-Peter Kiem, MD, PhD has focused on stem cell and transplantation biology, cell and gene therapy, and the development and use of novel gene-editing technologies. The overall goal has been the development of improved treatment approaches for patients with genetic and infectious diseases and cancer, in particular, hematologic malignancies. He is a […]
Steven Devine, MD
Steven Devine, MD is Associate Scientific Director/Senior Vice President of Research at the Center for International Blood and Marrow Transplant Research (CIBMTR), a research collaboration between the National Marrow Donor Program, also known as Be The Match, and the Medical College of Wisconsin. Steven is a board-certified oncologist and was the Director of the Blood […]